MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 129 filers reported holding MERSANA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 297.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47 | -61.5% | 37,356 | +1.0% | 0.00% | – |
| Q2 2023 | $122 | -20.3% | 36,993 | -0.3% | 0.00% | – |
| Q1 2023 | $153 | -53.4% | 37,108 | -33.7% | 0.00% | – |
| Q4 2022 | $328 | -99.9% | 55,981 | -0.0% | 0.00% | -100.0% |
| Q3 2022 | $379,000 | +68.4% | 56,001 | +15.0% | 0.00% | – |
| Q2 2022 | $225,000 | +15.4% | 48,705 | -0.2% | 0.00% | – |
| Q1 2022 | $195,000 | -39.4% | 48,823 | -5.8% | 0.00% | – |
| Q4 2021 | $322,000 | -34.2% | 51,808 | -0.1% | 0.00% | -100.0% |
| Q3 2021 | $489,000 | -39.4% | 51,864 | -12.8% | 0.00% | 0.0% |
| Q2 2021 | $807,000 | +3.3% | 59,445 | +23.1% | 0.00% | 0.0% |
| Q1 2021 | $781,000 | -39.2% | 48,300 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,285,000 | +64.3% | 48,300 | +15.0% | 0.00% | 0.0% |
| Q3 2020 | $782,000 | -20.4% | 42,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $983,000 | +530.1% | 42,000 | +56.7% | 0.00% | – |
| Q1 2020 | $156,000 | +132.8% | 26,800 | +129.1% | 0.00% | – |
| Q4 2019 | $67,000 | +272.2% | 11,700 | 0.0% | 0.00% | – |
| Q3 2019 | $18,000 | -87.9% | 11,700 | -68.1% | 0.00% | – |
| Q2 2019 | $149,000 | +132.8% | 36,700 | +203.3% | 0.00% | – |
| Q1 2019 | $64,000 | +30.6% | 12,100 | 0.0% | 0.00% | – |
| Q4 2018 | $49,000 | -59.5% | 12,100 | 0.0% | 0.00% | – |
| Q3 2018 | $121,000 | -44.0% | 12,100 | 0.0% | 0.00% | – |
| Q2 2018 | $216,000 | +13.1% | 12,100 | 0.0% | 0.00% | – |
| Q1 2018 | $191,000 | +253.7% | 12,100 | +266.7% | 0.00% | – |
| Q4 2017 | $54,000 | +217.6% | 3,300 | +230.0% | 0.00% | – |
| Q3 2017 | $17,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $40,026,000 | 4.69% |
| Opaleye Management Inc. | 1,047,000 | $4,837,000 | 2.18% |
| Sarissa Capital Management LP | 4,299,297 | $19,863,000 | 2.00% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $4,178,000 | 1.58% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 850,000 | $3,927,000 | 1.21% |
| Orbimed Advisors | 9,011,437 | $41,633,000 | 0.75% |
| Avoro Capital Advisors LLC | 7,550,000 | $34,881,000 | 0.69% |
| Rock Springs Capital Management LP | 4,075,958 | $18,831,000 | 0.55% |
| Artal Group S.A. | 2,200,000 | $10,164,000 | 0.54% |
| DAFNA Capital Management LLC | 406,763 | $1,879,000 | 0.51% |